Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8501228 | HORIZON | Stable compositions of famotidine and ibuprofen |
Jul, 2026
(2 years from now) | |
US8067451 | HORIZON | Methods and medicaments for administration of ibuprofen |
Jul, 2026
(2 years from now) | |
US8067033 | HORIZON | Stable compositions of famotidine and ibuprofen |
Jul, 2026
(2 years from now) | |
US8309127 | HORIZON | Stable compositions of famotidine and ibuprofen |
Jul, 2026
(2 years from now) | |
US8449910 | HORIZON | Stable compositions of famotidine and ibuprofen |
Jul, 2026
(2 years from now) | |
US8318202 | HORIZON | Stable compositions of famotidine and ibuprofen |
Jul, 2026
(2 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Combination(NC) | Apr 23, 2014 |
Market Authorisation Date: 23 April, 2011
Treatment: Relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for those indications
Dosage: TABLET;ORAL